IRCT20100110003032N3招募中2 期
Evaluation of the efficacy and safety of Nanojade twice daily versus Nanojade once daily in transfusion-dependent thalassemia patients
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 no limit（—）
- 性别
- All
入选标准
- •Age 2 years and older
- •Blood transfusion-dependent major beta-thalassemia
- •Under treatment with single iron chelator for at least 6 months and ferritin above 2500 ng/dL or patient with gastrointestinal side effects and ferritin above 2500 nd/d
排除标准
- •Unwillingness to participate in the study
研究者
相似试验
招募中
2 期
Evaluation of NLC nanoparticles containing hydroquinone, tretinoin, and fluocinolone in the treatment of melasmamelasma.L81.1ChloasmaIRCT20161207031288N13Tehran University of Medical Sciences20
已完成
2 期
Efficacy of topical Nano-liposomal Amphotericin B 0.4% for Treatment of OnychomycosisIRCT20150101020514N18Center For Research and Training in Skin Disease and Leprosy15
尚未招募
4 期
A study to compare the efficacy of nanobiofusion gel in the treatment of chronic periodontitis in smokers and non-smokers: A randomized controlled trialCTRI/2024/04/065484Dr Leanne Braganca
尚未招募
3 期
FAT THERAPY IN MALE AND FEMALE PATTERN BALDNESSCTRI/2023/09/058150Varsha M
招募中
2 期
EO-IMPACT: NEO-adjuvant chemo-IMmunotherapy in PAnCreaTic cancerPancreatic cancerCancer - PancreaticACTRN12622000378729Australasian Gastro-Intestinal Trials Group (AGITG)20